Drug Shortage Report for FLOVENT HFA
| Report ID | 217406 |
| Drug Identification Number | 02244292 |
| Brand name | FLOVENT HFA |
| Common or Proper name | fluticasone propionate inhalation aerosol |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | FLUTICASONE PROPIONATE |
| Strength(s) | 125MCG |
| Dosage form(s) | METERED-DOSE AEROSOL |
| Route of administration | ORAL INHALATION ORAL INHALATION |
| Packaging size | 1x60 |
| ATC code | R03BA |
| ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2024-01-23 |
| Estimated end date | 2024-03-08 |
| Actual end date | 2024-03-07 |
| Shortage status | Resolved |
| Updated date | 2024-03-08 |
| Company comments | Available in the 1x120 dose format. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-03-08 | French | Compare |
| v5 | 2024-03-08 | English | Compare |
| v4 | 2024-03-01 | French | Compare |
| v3 | 2024-03-01 | English | Compare |
| v2 | 2024-01-26 | French | Compare |
| v1 | 2024-01-26 | English | Compare |
Showing 1 to 6 of 6